Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026)
Vaxcyte (PCVX) reported Exchange Rate Effect of -$664000.0 for Q1 2026, down 156.66% year-over-year from $1.2 million in Q1 2025, and down 477.27% quarter-over-quarter from $176000.0 in Q4 2025.
Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 6 years of Exchange Rate Effect data on file, last reported at -$664000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$664000.0, down 156.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $603000.0 (up 113.51% YoY), and the FY2025 annual result was $2.4 million, up 472.54% from the prior year.
- Exchange Rate Effect slipped to -$664000.0 in Q1 2026 per PCVX's latest filing, from $176000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $6.1 million in Q1 2024 and troughed at -$7.7 million in Q4 2023.
- A 5-year average of -$255764.7 and a median of $53000.0 in 2022 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 26256.52% in 2024 and fell as far as 1707.69% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $796000.0 in 2022, then sank by 1065.08% to -$7.7 million in 2023, then soared by 117.57% to $1.3 million in 2024, then sank by 86.96% to $176000.0 in 2025, then sank by 477.27% to -$664000.0 in 2026.
- Business Quant data shows PCVX's Exchange Rate Effect at -$664000.0 in Q1 2026, $176000.0 in Q4 2025, and $291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | -664,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -664,000.00 |
| Mar 31, 2026 | -664,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Dec 31, 2023 | -7.68 Mn |
| Dec 31, 2023 | -7.68 Mn |